| Net Cash Provided by (Used in) Operating Activities |
$10,836,000 |
USD |
-1.8% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$9,353,000 |
USD |
-1044% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$26,455,000 |
USD |
314% |
Q2 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$6,266,000 |
USD |
|
Q2 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$4,902,000 |
USD |
2.2% |
Q3 2025 |
Q2 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$600,000 |
USD |
-40% |
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$58,660,000 |
USD |
-5.2% |
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$58,660,000 |
USD |
-5.2% |
Q1 2025 |
FY 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$96,000 |
USD |
-86% |
Q2 2025 |
Q1 2026 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$78,124,000 |
USD |
86% |
Q3 2025 |
Q2 2026 |
| Property, Plant and Equipment, Gross |
$12,373,000 |
USD |
19% |
Q1 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$24,296,000 |
USD |
38% |
Q1 2025 |
FY 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
$6,370,000 |
USD |
708% |
Q3 2025 |
Q2 2026 |
| Preferred Stock, Shares Authorized |
250,000,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Additional Paid in Capital |
$1,857,211,000 |
USD |
1.1% |
Q3 2025 |
Q2 2026 |
| Current State and Local Tax Expense (Benefit) |
$7,000 |
USD |
|
Q3 2025 |
Q2 2026 |
| Current Federal Tax Expense (Benefit) |
$8,000 |
USD |
-71% |
Q3 2025 |
Q2 2026 |
| Depreciation, Depletion and Amortization |
$242,000 |
USD |
-42% |
Q2 2025 |
Q1 2026 |
| Share-based Payment Arrangement, Expense |
$2,214,000 |
USD |
-72% |
Q3 2025 |
Q2 2026 |
| Interest Expense |
$17,559,000 |
USD |
13% |
Q1 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |